Cytometry Part B: Clinical Cytometry 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Flow cytometric false myeloperoxidase ‐positive childhood B‐lineage acute lymphoblastic leukemia
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 17, 2018 Category: Molecular Biology Authors: S üreyyaSavaşan
,
StevenBuck
,
ManishaGadgeel
,
AliGabali Source Type: research
Leptomeningeal myelomatosis diagnosed by an eight ‐color single tube in dried formulation. A case report
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 17, 2018 Category: Molecular Biology Source Type: research
Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5 ‐positive B‐cell neoplasms
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 17, 2018 Category: Molecular Biology Source Type: research
---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 17, 2018 Category: Molecular Biology Source Type: research
Detection of Fetomaternal Hemorrhage and ABO incompatibility
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 10, 2018 Category: Molecular Biology Authors: EitanFibach Source Type: research
Therapeutic potential of low ‐dose IL‐2 in immune thrombocytopenia: An analysis of 3 cases
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 10, 2018 Category: Molecular Biology Authors: JiakuiZhang
,
YanjieRuan
,
XuanxuanXu
,
HuipingWang
,
QianshanTao
,
JunLu
,
LinhuanXia
,
QiuyeZhang
,
JeffreyWang
,
YipingWang
,
ZhiminZhai Source Type: research
Detection of Fetomaternal Hemorrhage and ABO incompatibility
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 10, 2018 Category: Molecular Biology Source Type: research
Therapeutic potential of low ‐dose IL‐2 in immune thrombocytopenia: An analysis of 3 cases
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 10, 2018 Category: Molecular Biology Source Type: research
---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 10, 2018 Category: Molecular Biology Source Type: research
A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials
Conclusion: Our results highlight the reliability of this high‐standard protocol that could become a reference method for the monitoring of regulatory T cells in clinical trials. This article is protected by copyright. All rights reserved. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 6, 2018 Category: Molecular Biology Authors: Pitoiset Fabien, Barbi é Michèle, Monneret Guillaume, Braudeau Cécile, Pochard Pierre, Pellegrin Isabelle, Trauet Jacques, Labalette Myriam, Klatzmann David, Rosenzwajg Michelle Tags: Original Article Source Type: research
Flow Cytometric Aberrancies in Plasma Cell Myeloma and MGUS – Correlation with Laboratory Parameters
Conclusions: The plasma cells of PCM show a trend toward more antigenic aberrancy than those of MGUS. There is significant association between the antigenic profiles of PCM/MGUS and clinical parameters including amyloidosis, albumin level, and hemoglobin. This article is protected by copyright. All rights reserved. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - January 6, 2018 Category: Molecular Biology Authors: Sarika Gupta, Nitin J Karandikar, Timothy Ginader, Andrew M. Bellizzi, Carol J Holman Tags: Original Article Source Type: research
